WKHS Locations

Clinical Trials

Study Title

BUP 3031

Purpose

To characterize the safety and the pharmacokinetics (PK) of BTDS in patients of ages 7 to 16 years,inclusive, who require continuous opioid analgesia for moderate to severe pain.

Eligibility

Contact Principal Investigator for Information

Study Process

Contact Principal Investigator for Information

Trial Details

Principal Investigator:

Sunny Hussain, M.D.

IRB:

Quorum

IRB Number:

Trial Type:

Drug

Sponsor:

Purdue

Contact Information:

WK Pediatric GI Specialist
(318) 212-5858
http://www.wkpgis.com